105 related articles for article (PubMed ID: 1500491)
21. [Hirsutism: review and management. Apropos of 86 cases].
Belhadj H; Ben Slama C; Lamari D; Mebazaa A; Boukhris R
Tunis Med; 1986 Jan; 64(1):23-8. PubMed ID: 3715989
[No Abstract] [Full Text] [Related]
22. [Analysis of the results of treatment of idiopathic hirsutism and hirsutism in patients with polycystic ovary syndrome with androcur (cyproterone acetate)].
Baranowska B; Stopińska-Głuszak ; Niewiadomska A; Rozbicka G
Endokrynol Pol; 1983; 34(4):227-34. PubMed ID: 6228420
[No Abstract] [Full Text] [Related]
23. Hirsutism in the United Arab Emirates: a hospital study.
Gatee OB; Al Attia HM; Salama IA
Postgrad Med J; 1996 Mar; 72(845):168-71. PubMed ID: 8731709
[TBL] [Abstract][Full Text] [Related]
24. [Finasteride and flutamide in the treatment of hirsutism].
Falsetti L; De Fusco D; Rosina B
Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180
[TBL] [Abstract][Full Text] [Related]
25. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
Azziz R; Ehrmann D; Legro RS; Whitcomb RW; Hanley R; Fereshetian AG; O'Keefe M; Ghazzi MN;
J Clin Endocrinol Metab; 2001 Apr; 86(4):1626-32. PubMed ID: 11297595
[TBL] [Abstract][Full Text] [Related]
26. Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism.
Elkind-Hirsch KE; Anania C; Mack M; Malinak R
Fertil Steril; 1995 May; 63(5):970-8. PubMed ID: 7720941
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams J; Polson DW; Franks S
Br Med J (Clin Res Ed); 1986 Aug; 293(6543):355-9. PubMed ID: 3089520
[TBL] [Abstract][Full Text] [Related]
28. Treatment of hirsute women with cimetidine.
Vigersky RA; Mehlman I; Glass AR; Smith CE
N Engl J Med; 1980 Oct; 303(18):1042. PubMed ID: 7421891
[No Abstract] [Full Text] [Related]
29. Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome.
Pasquali R; Gambineri A
Eur J Endocrinol; 2014 Feb; 170(2):R75-90. PubMed ID: 24272197
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
[TBL] [Abstract][Full Text] [Related]
31. Risks related to the use of finasteride (propecia) in pregnant women.
Keller DL
Am Fam Physician; 2010 Jul; 82(2):102; author reply 102. PubMed ID: 20642261
[No Abstract] [Full Text] [Related]
32. The use of flutamide in the management of hirsutism.
Marugo M; Bernasconi D; Meozzi M; Del Monte P; Zino V; Primarolo P; Badaracco B
J Endocrinol Invest; 1994 Mar; 17(3):195-9. PubMed ID: 8051342
[TBL] [Abstract][Full Text] [Related]
33. The evaluation and treatment of androgen excess.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S241-7. PubMed ID: 17055833
[No Abstract] [Full Text] [Related]
34. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial.
Grant P
Phytother Res; 2010 Feb; 24(2):186-8. PubMed ID: 19585478
[TBL] [Abstract][Full Text] [Related]
35. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
36. Hirsutism and acne treated by an androgen antagonist.
Nelson RM; Rakoff AE
Obstet Gynecol; 1970 Nov; 36(5):748-52. PubMed ID: 4248736
[No Abstract] [Full Text] [Related]
37. [Androgenization in patients with polycystic ovary syndrome].
Gasparov AS; Pshenichnikova TIa; Alieva EA; Fedorova TA; Vetr M
Acta Univ Palacki Olomuc Fac Med; 1990; 126():241-6. PubMed ID: 2151091
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
39. What we see most, we understand least.
Agarwal SK; Judd HL
West J Med; 1996 Dec; 165(6):392-3. PubMed ID: 9000867
[No Abstract] [Full Text] [Related]
40. Diagnosis and management of hirsute women.
Badawy SZ
Int J Fertil; 1987; 32(5):349-57. PubMed ID: 2889680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
